Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Code:
NCT06335043
Conditions
Pharmacogenetic Testing to Determine Pharmacological Treatment in PTSD
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Pharmacogenetics Testing
Brief summary:
Conditions
Pharmacogenetic Testing to Determine Pharmacological Treatment in PTSD
Study ID
NCT06335043
Start date
Apr 25, 2024
Status verified date
Mar, 2025
Completion date
Apr 25, 2027
Anticipated
Primary completion date
Apr 25, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
155 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
no intervention: Mental Health Provider
experimental: Patient with Pharmacogenetic Testing
no intervention: Patient without Pharmacogenetic Testing
Interventions
Pharmacogenetics Testing
Primary outcome measure
Central contacts
Locations
MacDonald Franklin OSI Research and Innovation Centre
Recruiting
London, Ontario, Canada, N6C 0A7
Contacts
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Last update posted
Mar 13, 2025
Last verified
Mar, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's on 2025-03-13.